Company Search:
Advanced Search
Sponsored Links
Incyte Corp. Company Snapshot
Incyte Corp. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other companies in this sector in the United States: Exelixis, Inc. (2018 sales of $853.83 million of which 70% was CABOMETYX), Charles River Laboratories International Inc ($2.27 billion of which 58% was Discovery And Safety Assessment), and PRA Health Sciences Inc ($2.87 billion of which 91% was Clinical Research).

Sales Analysis. During the year ended December of 2018, sales at Incyte Corp. were $1.88 billion. This is an increase of 22.5% versus 2017, when the company's sales were $1.54 billion. This was the fifth consecutive year of sales increases at Incyte Corp. (and since 2013, sales have increased a total of 430%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Incyte Corp.
  Stock Performance Chart for Incyte Corp.
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 76.12
(Figures in U.S. Dollars)
1 Week 1.7%   13 Weeks -0.4%  
4 Weeks -5.0%   52 Weeks 21.7%  
Incyte Corp. Key Data:
  Ticker: INCY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2018 Sales 1,881,883,000
(Year Ending Jan 2019).
Employees: 1,367
  Currency: U.S. Dollars Market Cap: 16,370,871,799
  Fiscal Yr Ends: December Shares Outstanding: 215,066,629
  Share Type: Common Closely Held Shares: 1,105,217
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.